Migrational changes of mesenchymal stem cells in response to cytokines, growth factors, hypoxia, and aging

Experimental Cell Research

Volumn 338, Issue 1, 2015, Pages 97-104

  Naaldijk, Yahaira ^a,b   Johnson, Adiv A ^c   Ishak, Stefan ^a   Meisel, Hans Jörg ^d   Hohaus, Christian ^d   Stolzing, Alexandra ^b,e  

^a FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c MAYO CLINIC   (United States)

^d BG KLINIKEN BERGMANNSTROST   (Germany)

^e LOUGHBOROUGH UNIVERSITY   (United Kingdom)

Author keywords

Chemokine; Inflammation; Migration; Scratch assay; Senescence; Transmigration

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; GAMMA INTERFERON; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN C; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; OXYGEN; SIGNAL PEPTIDE;

AGED; AGING; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HYPOXIA; MESENCHYMAL STEM CELL; MTT ASSAY; NONHUMAN; OXYGEN CONCENTRATION; PHENOTYPE; PRIORITY JOURNAL; RAT; SENESCENCE; SUBCUTANEOUS FAT; ANIMAL; CELL AGING; CELL CULTURE; CELL HYPOXIA; CELL MOTION; HUMAN; MESENCHYMAL STROMA CELL; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

AGING; ANIMALS; CELL AGING; CELL DIFFERENTIATION; CELL HYPOXIA; CELL MOVEMENT; CELLS, CULTURED; CYTOKINES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESENCHYMAL STROMAL CELLS; OXYGEN; RATS, SPRAGUE-DAWLEY;

EID: 84942196593     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2015.08.019     Document Type: Article

References (56)

1. Friedenstein A.J., Chailakhyan R.K., Latsinik N.V., Panasyuk A.F., Keiliss-Borok I.V. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 1974, 17:331-340.
2. Friedenstein A.J., Deriglasova U.F., Kulagina N.N., Panasuk A.F., Rudakowa S.F., Luria E.A., Ruadkow I.A. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp. Hematol. 1974, 2:83-92.
3. Hass R., Kasper C., Bohm S., Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun. Signal 2011, 9:12.
4. Sohni A., Verfaillie C.M. Mesenchymal stem cells migration homing and tracking. Stem Cells Int. 2013, 2013:130763.
5. Sethe S., Scutt A., Stolzing A. Aging of mesenchymal stem cells. Ageing Res. Rev. 2006, 5:91-116.
6. Rohani L., Johnson A.A., Arnold A., Stolzing A. The aging signature: a hallmark of induced pluripotent stem cells?. Aging Cell 2014, 13:2-7.
7. Campioni D., Rizzo R., Stignani M., Melchiorri L., Ferrari L., Moretti S., Russo A., Bagnara G.P., Bonsi L., Alviano F., Lanzoni G., Cuneo A., Baricordi O.R., Lanza F. A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs. Cytom. B Clin. Cytom. 2009, 76:225-230.
8. Toubai T., Paczesny S., Shono Y., Tanaka J., Lowler K.P., Malter C.T., Kasai M., Imamura M. Mesenchymal stem cells for treatment and prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation. Curr. Stem Cell Res. Ther. 2009, 4:252-259.
9. Delalat B., Pourfathollah A.A., Soleimani M., Mozdarani H., Ghaemi S.R., Movassaghpour A.A., Kaviani S. Isolation and ex vivo expansion of human umbilical cord blood-derived CD34+ stem cells and their cotransplantation with or without mesenchymal stem cells. Hematology 2009, 14:125-132.
10. Breyner N.M., Hell R.C., Carvalho L.R., Machado C.B., Peixoto Filho I.N., Valerio P., Pereira M.M., Goes A.M. Effect of a three-dimensional chitosan porous scaffold on the differentiation of mesenchymal stem cells into chondrocytes. Cells Tissues Organs 2010, 191:119-128.
11. Tang Y.L., Tang Y., Zhang Y.C., Qian K., Shen L., Phillips M.I. Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J. Am. Coll. Cardiol. 2005, 46:1339-1350.
12. Sasaki M., Abe R., Fujita Y., Ando S., Inokuma D., Shimizu H. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J. Immunol. 2008, 180:2581-2587.
13. Walter M.N., Wright K.T., Fuller H.R., MacNeil S., Johnson W.E. Mesenchymal stem cell-conditioned medium accelerates skin wound healing: an in vitro study of fibroblast and keratinocyte scratch assays. Exp. Cell. Res. 2010, 316:1271-1281.
14. Markel T.A., Crisostomo P.R., Manukyan M.C., Al-Azzawi D., Herring C.M., Lahm T., Novotny N.M., Meldrum D.R. Are neonatal stem cells as effective as adult stem cells in providing ischemic protection?. J. Surg. Res. 2009, 152:325-330.
15. Umar S., de Visser Y.P., Steendijk P., Schutte C.I., Laghmani el H., Wagenaar G.T., Bax W.H., Mantikou E., Pijnappels D.A., Atsma D.E., Schalij M.J., van der Wall E.E., van der Laarse A. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H1606-H1616.
16. Lopes J.P., Fiarresga A., Silva Cunha P., Feliciano J., Ferreira R.Cruz Mesenchymal stem cell therapy in heart disease. Rev. Port. Cardiol. 2013, 32:43-47.
17. Barbash I.M., Chouraqui P., Baron J., Feinberg M.S., Etzion S., Tessone A., Miller L., Guetta E., Zipori D., Kedes L.H., Kloner R.A., Leor J. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 2003, 108:863-868.
18. Ortiz L.A., Gambelli F., McBride C., Gaupp D., Baddoo M., Kaminski N., Phinney D.G. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc. Natl. Acad. Sci. USA 2003, 100:8407-8411.
19. Akram K.M., Samad S., Spiteri M.A., Forsyth N.R. Mesenchymal stem cells promote alveolar epithelial cell wound repair in vitro through distinct migratory and paracrine mechanisms. Respir. Res. 2013, 14:9.
20. Joyce N.C., Harris D.L., Markov V., Zhang Z., Saitta B. Potential of human umbilical cord blood mesenchymal stem cells to heal damaged corneal endothelium. Mol. Vis. 2012, 18:547-564.
21. Manuguerra-Gagne R., Boulos P.R., Ammar A., Leblond F.A., Krosl G., Pichette V., Lesk M.R., Roy D.C. Transplantation of mesenchymal stem cells promotes tissue regeneration in a glaucoma model through laser-induced paracrine factor secretion and progenitor cell recruitment. Stem Cells 2013, 31:1136-1148.
22. Li Q., Zhou X., Shi Y., Li J., Zheng L., Cui L., Zhang J., Wang L., Han Z., Han Y., Fan D. In vivo tracking and comparison of the therapeutic effects of MSCs and HSCs for liver injury. PLoS One 2013, 8:e62363.
23. Dong F., Harvey J., Finan A., Weber K., Agarwal U., Penn M.S. Myocardial CXCR4 expression is required for mesenchymal stem cell mediated repair following acute myocardial infarction. Circulation 2012, 126:314-324.
24. Wang Y., Deng Y., Zhou G.Q. SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model. Brain Res. 2008, 1195:104-112.
25. Marquez-Curtis L.A., Janowska-Wieczorek A. Enhancing the migration ability of mesenchymal stromal cells by targeting the SDF-1/CXCR4 axis. Biomed. Res. Int. 2013, 2013:561098.
26. Duscher D., Rennert R.C., Januszyk M., Anghel E., Maan Z.N., Whittam A.J., Perez M.G., Kosaraju R., Hu M.S., Walmsley G.G., Atashroo D., Khong S., Butte A.J., Gurtner G.C. Aging disrupts cell subpopulation dynamics and diminishes the function of mesenchymal stem cells. Sci. Rep. 2014, 4:7144.
27. Li L., Guo Y., Zhai H., Yin Y., Zhang J., Chen H., Wang L., Li N., Liu R., Xia Y. Aging increases the susceptivity of MSCs to reactive oxygen species and impairs their therapeutic potency for myocardial infarction. PLoS One 2014, 9:e111850.
28. Schmidt A., Ladage D., Schinkothe T., Klausmann U., Ulrichs C., Klinz F.J., Brixius K., Arnhold S., Desai B., Mehlhorn U., Schwinger R.H., Staib P., Addicks K., Bloch W. Basic fibroblast growth factor controls migration in human mesenchymal stem cells. Stem Cells 2006, 24:1750-1758.
29. Jaganathan B.G., Ruester B., Dressel L., Stein S., Grez M., Seifried E., Henschler R. Rho inhibition induces migration of mesenchymal stromal cells. Stem Cells 2007, 25:1966-1974.
30. Maijenburg M.W., van der Schoot C.E., Voermans C. Mesenchymal stromal cell migration: possibilities to improve cellular therapy. Stem Cells Dev. 2012, 21:19-29.
31. Kean T.J., Lin P., Caplan A.I., Dennis J.E. MSCs: delivery routes and engraftment, cell-targeting strategies, and immune modulation. Stem Cells Int. 2013, 2013:732742.
32. Annabi B., Lee Y.T., Turcotte S., Naud E., Desrosiers R.R., Champagne M., Eliopoulos N., Galipeau J., Beliveau R. Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation. Stem Cells 2003, 21:337-347.
33. Rosova I., Dao M., Capoccia B., Link D., Nolta J.A. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 2008, 26:2173-2182.
34. Xinaris C., Morigi M., Benedetti V., Imberti B., Fabricio A.S., Squarcina E., Benigni A., Gagliardini E., Remuzzi G. A novel strategy to enhance mesenchymal stem cell migration capacity and promote tissue repair in an injury specific fashion. Cell Transpl. 2013, 22:423-436.
35. Dobson K.R., Reading L., Haberey M., Marine X., Scutt A. Centrifugal isolation of bone marrow from bone: an improved method for the recovery and quantitation of bone marrow osteoprogenitor cells from rat tibiae and femurae. Calcif. Tissue Int. 1999, 65:411-413.
36. Naaldijk Y., Staude M., Fedorova V., Stolzing A. Effect of different freezing rates during cryopreservation of rat mesenchymal stem cells using combinations of hydroxyethyl starch and dimethylsulfoxide. BMC Biotechnol. 2012, 12:49.
37. Sekiya I., Larson B.L., Smith J.R., Pochampally R., Cui J.G., Prockop D.J. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 2002, 20:530-541.
38. Buyl K., Vanhaecke T., Desmae T., Lagneaux L., Rogiers V., Najar M., De Kock J. Evaluation of a new standardized enzymatic isolation protocol for human umbilical cord-derived stem cells. Toxicol. In Vitro 2014.
39. Naaldijk Y., Federova V., Stolzing A. Cryopreservation of human umbilical cord-derived mesenchymal stem cells in complex sugar based cryoprotective solutions. J. Biotechnol. Lett. 2013, 4:95.
40. Liang C.C., Park A.Y., Guan J.L. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat. Protoc. 2007, 2:329-333.
41. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
42. Xiao Q., Wang S.K., Tian H., Xin L., Zou Z.G., Hu Y.L., Chang C.M., Wang X.Y., Yin Q.S., Zhang X.H., Wang L.Y. TNF-alpha increases bone marrow mesenchymal stem cell migration to ischemic tissues. Cell Biochem. Biophys. 2012, 62:409-414.
43. Huang Y.L., Qiu R.F., Mai W.Y., Kuang J., Cai X.Y., Dong Y.G., Hu Y.Z., Song Y.B., Cai A.P., Jiang Z.G. Effects of insulin-like growth factor-1 on the properties of mesenchymal stem cells in vitro. J. Zhejiang Univ. Sci. B 2012, 13:20-28.
44. Ball S.G., Shuttleworth C.A., Kielty C.M. Vascular endothelial growth factor can signal through platelet-derived growth factor receptors. J. Cell Biol. 2007, 177:489-500.
45. Li A., Xia X., Yeh J., Kua H., Liu H., Mishina Y., Hao A., Li B. PDGF-AA promotes osteogenic differentiation and migration of mesenchymal stem cell by down-regulating PDGFRalpha and derepressing BMP-Smad1/5/8 signaling. PLoS One 2014, 9:e113785.
46. Veevers-Lowe J., Ball S.G., Shuttleworth A., Kielty C.M. Mesenchymal stem cell migration is regulated by fibronectin through alpha5beta1-integrin-mediated activation of PDGFR-beta and potentiation of growth factor signals. J. Cell Sci. 2011, 124:1288-1300.
47. Liu X., Duan B., Cheng Z., Jia X., Mao L., Fu H., Che Y., Ou L., Liu L., Kong D. SDF-1/CXCR4 axis modulates bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion. Protein Cell 2011, 2:845-854.
48. Ponte A.L., Marais E., Gallay N., Langonne A., Delorme B., Herault O., Charbord P., Domenech J. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007, 25:1737-1745.
49. Liu H., Xue W., Ge G., Luo X., Li Y., Xiang H., Ding X., Tian P., Tian X. Hypoxic preconditioning advances CXCR4 and CXCR7 expression by activating HIF-1alpha in MSCs. Biochem. Biophys. Res. Commun. 2010, 401:509-515.
50. Liu Y., Cox S.R., Morita T., Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer. Circ. Res. 1995, 77:638-643.
51. Pham I., Uchida T., Planes C., Ware L.B., Kaner R., Matthay M.A., Clerici C. Hypoxia upregulates VEGF expression in alveolar epithelial cells in vitro and in vivo. Am. J. Physiol. Lung Cell Mol. Physiol. 2002, 283:L1133-L1142.
52. Lozito T.P., Tuan R.S. Mesenchymal stem cells inhibit both endogenous and exogenous MMPs via secreted TIMPs. J. Cell Physiol. 2011, 226:385-396.
53. Schoenborn J.R., Wilson C.B. Regulation of interferon-gamma during innate and adaptive immune responses. Adv. Immunol. 2007, 96:41-101.
54. Glover L.E., Irizarry K., Scully M., Campbell E.L., Bowers B.E., Aherne C.M., Kominsky D.J., MacManus C.F., Colgan S.P. IFN-gamma attenuates hypoxia-inducible factor (HIF) activity in intestinal epithelial cells through transcriptional repression of HIF-1beta. J. Immunol. 2011, 186:1790-1798.
55. Hu X., Yu S.P., Fraser J.L., Lu Z., Ogle M.E., Wang J.A., Wei L. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J. Thorac. Cardiovasc. Surg. 2008, 135:799-808.
56. Bustos M.L., Huleihel L., Kapetanaki M.G., Lino-Cardenas C.L., Mroz L., Ellis B.M., McVerry B.J., Richards T.J., Kaminski N., Cerdenes N., Mora A.L., Rojas M. Aging mesenchymal stem cells fail to protect because of impaired migration and antiinflammatory response. Am. J. Respir. Crit. Care Med. 2014, 189:787-798.